PRESS-RELEASE ·Filed Mar 3, 2026
Press release · Earnings
Actionable Insight • Neutral
Traders should prepare for the earnings release and call on March 17, where actual financial performance and guidance will be revealed. Watch for revenue trends, EPS, and any commentary on device adoption or regulatory progress.
Final — all horizons settled through T+60d
KMTS ▼ -8.38% at T+60d
NEUTRAL call -8.38% · α vs SPY -18.69% · entry $22.92 → $21.00
T+1d
-2.75%
call -2.75% · α -3.51%
$22.29
settled 8mo ago
T+5d
-2.75%
call -2.75% · α -2.27%
$22.29
settled 8mo ago
T+20d
-13.05%
call -13.05% · α -8.64%
$19.93
settled 7mo ago
T+60d
-8.38%
call -8.38% · α -18.69%
$21.00
settled 5mo ago
Price Chart
Loading chart...
Executive Summary
Kestra Medical Technologies announced it will report its Q3 fiscal 2026 financial results on March 17, 2026, followed by a management conference call. No financial data was released in this announcement.
Key Facts
- Kestra Medical Technologies will report Q3 FY2026 financial results on March 17, 2026.
- Management will host a conference call at 4:30 p.m. Eastern Time.
- No financial results or guidance were disclosed in this press release.
- The announcement serves as a scheduling notice for investors and analysts.
Financial Impact
No financial impact from this announcement alone — actual results to be disclosed on March 17.
Risk Factors
- Earnings could miss expectations given lack of pre-announcement or positive signals.
- No upward guidance or preliminary data provided, increasing potential for negative surprise.
Market Snapshot
Exchange
Nasdaq
Investment Themes
Healthcare & Medical Devices
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3248123 |
18 reports for KMTS
100% Hit rate @ T+20 Went positive at some point 4 of 5 best @ T+20▲ +15.82%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 5d ago | Insider Cluster | $28.76 | awaiting T+20 | — | $29.42 (+2.29%) |
Oct 20, 2026 6d ago | 144 | $27.31 | awaiting T+20 | — | $29.42 (+7.73%) |
Oct 20, 2026 6d ago | ANALYST-UPGRADE | $28.28 | awaiting T+20 | — | $29.42 (+4.03%) |
Sep 30, 2026 26d ago | 144 | $27.12 | awaiting T+20 | — | $29.42 (+8.50%) |
Sep 14, 2026 6w ago | Press Release | $25.18 $26.97 | ▲ +7.11% | ▲ +4.39% | $29.42 (+16.84%) |
Sep 10, 2026 6w ago | Insider Cluster | $22.85 $26.98 | ▲ +18.07% | ▲ +16.21% | $29.42 (+28.75%) |
Sep 10, 2026 6w ago | Press Release | $23.57 $25.77 | ▲ +9.33% | ▲ +7.21% | $29.42 (+24.82%) |
Aug 31, 2026 8w ago | Press Release | $25.12 $28.29 | ▲ +12.62% | ▲ +12.30% | $29.42 (+17.12%) |
Aug 26, 2026 8w ago | Press Release | $26.57 $25.76 | ▼ −3.05% | ▼ −3.27% | $29.42 (+10.73%) |
Aug 11, 2026 10w ago | Insider Cluster | $28.00 $23.57 | ▲ +15.82% | ▲ +13.92% | $29.42 (−5.07%) |
Showing 10 of 18
US Market Status
Market Closed — Opens in 3h 11m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers